Marie-laure L. Tanguy

Villejuif, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Villejuif, FR 

Overview

Marie-laure Tanguy practices practicing medicine in Villejuif, France.

Their clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Breast Cancer, Fibroadenoma, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).

They are actively involved in clinical research, co-authoring 50 peer reviewed articles and participating in 1 clinical trial.

Locations

Villejuif, 94805, France
Other Locations
Brest, France
Paris, France
Tours, France
Saint Cloud, France
9, Avenue De La Forêt De Haye, Nancy, 54505, France
Université Paris Est Créteil, INSERM U955, Fondation FondaMental, Creteil, France
Balma, 31138, France
1, Rue Haute De Reculée, 49045 Angers Cedex 01, Angers, 49045, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Evaluation of a Nurse-led Program for the Prevention of Complications of Long-term Corticosteroid Therapy
Evaluation of a Nurse-led Program for the Prevention of Complications of Long-term Corticosteroid Therapy
Enrollment Status: Recruiting
Publish Date: March 20, 2026
Intervention Type: Other
Study Phase: Not Applicable

50 Total Publications

Treatment Intensification with Hepatic Arterial Infusion Chemotherapy in Patients with Liver-Only Colorectal Metastases Still Unresectable After Systemic Induction Chemotherapy: Exploratory Findings From a Prematurely Closed Multicenter Randomized Phase II Study: SULTAN UCGI 30/PRODIGE 53 (NCT03164655).
Treatment Intensification with Hepatic Arterial Infusion Chemotherapy in Patients with Liver-Only Colorectal Metastases Still Unresectable After Systemic Induction Chemotherapy: Exploratory Findings From a Prematurely Closed Multicenter Randomized Phase II Study: SULTAN UCGI 30/PRODIGE 53 (NCT03164655).
Journal: Annals of surgical oncology
Published: July 24, 2025

Frequently Asked Questions about Marie-laure L. Tanguy

Is Marie-laure L. Tanguy a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Marie-laure L. Tanguy is classified as an Experienced expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marie-laure L. Tanguy participate in research or clinical trials?

Yes. Marie-laure L. Tanguy has published 50 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Marie-laure L. Tanguy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Tanguy's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile